Executive Summary
Across 50 8-K filings from March 2026, dominant themes include a surge in M&A transactions (10+ deals like Repay-KUBRA, SCYNEXIS-SCY-770, Red Cat-Quaze), debt refinancings/extensions (Alerus, Prologis, Ares, Lincoln National), and widespread executive changes/appointments (20+ instances, notably Jay Jacobs replacing Shannon Ghia across 8 BlackRock iShares ETF sponsors). Period-over-period trends show revenue growth in standout performers like nCino (+10% FY2026 YoY to $594.8M, first GAAP profit) and T1 Energy (record Q4 production 1.13GW YoY, FY 2.79GW in-line), but persistent losses (T1 Q4 net loss $190M improved from $367M). Forward-looking catalysts cluster in Q2 2026 (merger closings, M&A approvals), with positive guidance in payments/energy/biotech offsetting bankruptcy (Lipella) and wind-downs (Allbirds). Portfolio-level patterns reveal financials/real estate leaning toward neutral refinancing for stability, while biotech/tech exhibit bullish expansion via tuck-ins and equity raises. Capital allocation favors M&A reinvestment over dividends/buybacks, signaling growth conviction amid mixed sentiment (25% positive, 10% negative). Actionable implications: overweight fintech/biotech M&A plays, monitor ETF sponsor stability, avoid distressed pharma.
Tracking the trend? Catch up on the prior US Material Events SEC 8-K Filings digest from March 25, 2026.
Investment Signals(12)
- Repay Holdings↓(BULLISH)▲
Definitive agreement to acquire KUBRA for $372M cash/debt, pro forma 2025 rev $548M (+synergies $15M+ run-rate), 25% FCF accretion by 2028, expands to utilities/insurance
- nCino↓(BULLISH)▲
Record Q4 FY2026 rev $149.7M (+6% YoY vs $141.4M), FY rev $594.8M (+10% YoY), turned GAAP profitable Q4 $8.3M (from -$18.6M loss), FY $5.2M profit, ACV +17% YoY
- T1 Energy↓(BULLISH)▲
Record Q4 2025 module prod 1.13GW (YoY record), FY prod 2.79GW in-line guidance, Q4 net loss $190M improved from $367M YoY, 2026 guidance maintained 3.1-4.2GW w/3GW contracted
- Trailblazer/Cyabra↓(BULLISH)▲
Completed SPAC business combo closing Mar 27, 2026, common stock trading Nasdaq CYAB Mar 27, first public co fighting disinformation
- SCYNEXIS (Acq)(BULLISH)▲
Completed SCY-770 acquisition upfront $8M (+milestones), Phase 2 POC study Q4 2026 readout 2H2027, bolsters ADPKD pipeline w/Orphan Drug status
- SCYNEXIS (PP)(BULLISH)▲
$40M private placement (potentially $52.2M full exercise), funds ops to mid-2029, CEO bought 108k shares signaling conviction
- Red Cat Holdings↓(BULLISH)▲
Acquired Quaze Technologies for $25M shares (+$5M earnout on rev/margins), closes subject to approvals by Dec 31, 2026
- Satellogic↓(BULLISH)▲
Entered $50M ATM offering w/Cantor Fitzgerald et al via S-3, enables flexible equity capital raise
- First Foundation↓(BULLISH)▲
Fed Reserve merger approval w/FirstSun, all approvals secured, closure Apr 1, 2026 w/exec continuity via amended agreements
- BrightSpring Health↓(BULLISH)▲
Completed ResCare divestiture to Sevita Mar 31, 2026, sharpens focus on Provider Services (home health/personal care)
- High Roller Technologies↓(BULLISH)▲
Board approved $250k CEO bonus/$50k CFO bonus Mar 25, 2026, signals performance alignment
- Toll Brothers↓(BULLISH)▲
CEO succession complete Mar 30, Karl Mistry new CEO, Douglas Yearley to Exec Chairman, board expanded to 10
Risk Flags(8)
- Lipella Pharmaceuticals/Bankruptcy↓[HIGH RISK]▼
Filed Chapter 11 Mar 30, 2026, trading highly speculative w/substantial shareholder recovery risks
- Allbirds/Asset Sale↓[HIGH RISK]▼
Selling IP/assets to AXNY for ~$39M, requires shareholder vote by Apr 24 proxy, leads to Q2 close/Q3 dissolution
- Soulpower Acquisition/SPAC Delay↓[MEDIUM RISK]▼
BCA amended to add Uruguay Iron Mine, pro forma $8.5B val, but closing delayed to late Q2/Q3 2026 from Nov 2025
- T1 Energy/Losses↓[MEDIUM RISK]▼
Q4 2025 net loss $190M (improved YoY but large), FY loss $380.8M, remaining $350M capex for G2 Phase 1
- iPower/Prom Note Amend↓[MEDIUM RISK]▼
$2.3M note amendment expands 'Change of Control' triggers (exec/board changes), heightens repayment risk post-GPM sale
- New ERA Energy/Debt Add↓[MEDIUM RISK]▼
Paid $4.35M (cash+note due Jul 2026) to eliminate repurchase rights on 440 acres, plus 2.1M share issuance diluting equity
- Shimmick/CEO Retirement↓[LOW-MEDIUM RISK]▼
Steven Richards retiring end-2026 term, board shrinks to 5, post-IPO leader exit amid emerging growth status
- Barinthus Biotherapeutics/PAO Departure↓[LOW-MEDIUM RISK]▼
Gemma Jones stepping down Apr 30, 2026, no successor named
Opportunities(8)
- Repay Holdings/M&A Synergies↓(OPPORTUNITY)◆
KUBRA deal projects $178M Adj EBITDA, $130B payment vol, cost synergies $15M+, net leverage <3.0x in 18mos post-Q2 2026 close
- nCino/Growth Guidance↓(OPPORTUNITY)◆
Q1 FY27 rev guide $154.5-156.5M, FY27 $639-643M (+8% YoY), FCF $132-137M, ACV $662.5-667.5M (+10% YoY), new wins w/$2T bank
- SCYNEXIS/Pipeline Catalysts↓(OPPORTUNITY)◆
SCY-770 Phase 2 Q4 2026/2H27 readout + SCY-247 Phase1 IV Q3 2026, funded to 2029, BREXAFEMME licensed GSK
- T1 Energy/Capacity Ramp↓(OPPORTUNITY)◆
G2 Phase1 2.1GW on-schedule Q4 2026 start, 2027 Adj EBITDA $375-450M run-rate, full 5GW $650-700M, $160M PTC sale
- First Foundation/Merger Close↓(OPPORTUNITY)◆
All approvals in, merger w/FirstSun closes Apr 1, 2026, exec retention via extended agreements
- Satellogic/ATM Equity↓(OPPORTUNITY)◆
$50M at-market offering flexibility for growth funding, post-S-3 effective
- Trailblazer/Cyabra/SPAC↓(OPPORTUNITY)◆
Post-close trading CYAB Mar 27, unique disinformation analytics play
- Ellington Credit/Notes Offering↓(OPPORTUNITY)◆
$50M 8.5% Notes due 2031 (+$7.5M option), quarterly pay starting Jun 30, redeemable 2028, NYSE ELLA
Sector Themes(6)
- ETF Sponsor Leadership Overhaul◆
8 iShares trusts (Bitcoin, Gold Micro, Staked ETH, GSCI, Gold, Silver, ETHA) simultaneously appointed Jay Jacobs (BlackRock MD, ex-Global X) as Sponsor CEO/President Mar 27, replacing Shannon Ghia (no disputes), neutral continuity w/ETF expertise boost
- M&A Acceleration in Payments/Biotech◆
8 deals (Repay-KUBRA $372M, Red Cat-Quaze $25-30M, SCYNEXIS-SCY770 $8M+, Soulpower $8.5B pro forma, BrightSpring divest, Allbirds $39M sale) signal consolidation for synergies/expansion, avg materiality 9/10, Q2 2026 cluster
- Debt Refinancing/Stability in Financials/RE◆
7 firms (Alerus extend to 2036 6.75%, Prologis global credit, Ares 3yr DD term loan, Lincoln $2B to 2031, Ellington $50M notes, Willis termination) prioritize liquidity/covenant tweaks amid neutral sentiment, no draw details but rating-linked margins
- Biotech Pipeline Builds w/Funding◆
SCYNEXIS acq+PP ($40-52M to 2029), Immunic Phase3 MS data end-2026, appointments (Congleton, Gilliland) add comm/AI expertise, positive sentiment offsets Lipella BK outlier
- Exec Churn/Continuity in Banks/Tech◆
15+ appointments/resignations/retirements (First Foundation retention, Toll Bros CEO swap, nCino growth hires, SmartFinancial COO promo), mostly neutral/positive, pre-merger/M&A stability
- Energy/Infra Expansion Amid Losses◆
T1 record GW prod but losses improving YoY, New ERA property secures for data centers w/short debt, capex ramps to 2027 EBITDA targets
Watch List(8)
Q2 2026 KUBRA close subject to US/Canada regs, call Mar 31 8AM ET for synergy details [Mar 31, 2026]
BCA amend closing late Q2/Q3 2026, S-4 public Q2 2026, monitor redemptions at $10/share val [Q2-Q3 2026]
Closure expected Apr 1, 2026 post-Fed approval, watch integration [Apr 1, 2026]
SCY-770 Phase2 Q4 2026, SCY-247 Q3 2026, PP close ~Apr 1, call Mar 31 8:30AM ET [Mar 31 & Q3-Q4 2026]
Proxy by Apr 24 2026 for $39M asset sale/Q2 close/Q3 distribution [Apr 24, 2026]
2.1GW Phase1 on-schedule Q4 2026 prod start, $350M remaining capex [Q4 2026]
Monitor $50M Class A share sales via agents post-S-3 [Ongoing 2026]
Vidofludimus calcium top-line relapsing MS end-2026 [End-2026]
Filing Analyses(50)
31-03-2026
Alerus Financial Corporation entered into a Modification Agreement dated March 30, 2026, with the Bank of North Dakota to amend its Subordinated Note originally issued in 2021 for $50,000,000 principal, which remains outstanding along with $1,769,444.44 in accrued interest and fees for a total of $51,769,444.44. Key changes include extending the maturity date to March 30, 2036, setting a fixed interest rate of 6.75% until March 30, 2031 followed by a variable rate, and allowing prepayments without penalty starting March 30, 2031. The agreement also updates various covenants referencing no material adverse changes since December 31, 2025, and adds requirements for insurance and Bank Subsidiary financial condition monitoring.
- ·Prepayment permitted on or after March 30, 2031 with five business days' notice, in minimums of $500,000 or integral multiples of $100,000, without penalty.
- ·No prepayment allowed before March 30, 2031 except in cases of Tier 2 Capital disqualification, Tax Event, or Investment Company Act registration requirement.
- ·New covenant requires Borrower and subsidiaries to maintain customary insurance, with evidence provided to Lender.
- ·Bank Subsidiary must report if leverage ratio <8.25%, total risk-based capital <10.50%, Texas Ratio >25%, or loans/assets >85%, potentially requiring executive summary.
31-03-2026
T1 Energy reported record Q4 2025 module production of 1.13 GW at G1_Dallas, generating record net sales of $358.5 million, with full-year production of 2.79 GW in line with guidance. However, the company recorded a Q4 net loss attributable to common stockholders of $190.0 million (improved from $367.2 million in Q4 2024) and full-year net loss of $380.8 million (versus $450.2 million in 2024). Construction on the 2.1 GW Phase 1 of G2_Austin is on schedule for Q4 2026 production start, with remaining capital spending of approximately $350 million.
- ·2026 production and sales guidance maintained at 3.1 – 4.2 GW with 3 GW contracted.
- ·Annualized run-rate Adjusted EBITDA guidance: $375 - $450 million in 2027 upon G2 Phase 1 completion; $650 - $700 million at full 5 GW integrated G1/G2 production.
- ·First sale of Section 45X PTCs for $160 million at $0.91 per dollar to a U.S. financial institution.
- ·Three-year contract with Treaty Oak for minimum 900 MW of solar modules.
- ·Construction start on G2_Austin Phase 1 in December 2025, anticipated $400 - $425 million total capex.
31-03-2026
Repay Holdings Corporation (RPAY) announced a definitive agreement to acquire KUBRA for approximately $372 million in cash, financed by cash on hand and debt, creating a combined entity with projected 2025 revenue of $548 million and Adjusted EBITDA of $178 million, alongside over $130 billion in annual payment volumes. The deal is expected to deliver $15+ million in annual run-rate cost synergies, $5+ million in technology savings over three years, and 25% Free Cash Flow accretion by 2028, while expanding into utilities, government, and insurance verticals serving 250 clients and 40% of US/Canada households. The transaction anticipates closing in Q2 2026, subject to regulatory approvals, with expected net leverage of 4.0x at close reducing below 3.0x within 18 months.
- ·KUBRA founded in 1992, headquartered in Mississauga, Ontario
- ·Conference call scheduled for March 31, 2026 at 8:00 AM ET
- ·Transaction subject to US and Canada regulatory approvals and customary closing conditions
- ·Advisors: Truist Securities (financial to REPAY), Troutman Pepper Locke (legal to REPAY), Financial Technology Partners (financial to KUBRA), Clifford Chance US LLP and Hearst Office of General Counsel (legal to KUBRA)
31-03-2026
Soulpower Acquisition Corporation (NYSE:SOUL) and SWB Holdings amended their Business Combination Agreement, adding an acquisition of Uruguay Iron Mine with approximately 1,170 million tons of estimated resources while eliminating certain other assets from contributions, resulting in a pro forma combined company valuation of approximately $8.5 billion assuming no redemptions and $10/share valuation. The amendment includes procedural updates and was unanimously approved by Soulpower's board and special committee. Closing is now anticipated in late Q2 or Q3 2026, later than the original November 2025 announcement, subject to shareholder approval, regulatory conditions, and customary closing requirements.
- ·Soulpower IPO underwritten by Cantor Fitzgerald in April 2025
- ·Confidential draft Form S-4 submitted December 30, 2025; public filing expected Q2 2026
- ·Pubco Class A Ordinary Shares to list on NYSE under ticker SOUL post-closing
- ·SOUL WORLD BANK™ banking license pending BVI regulatory and Court approvals
- ·Certain excluded assets may be considered for post-closing acquisition by Pubco
31-03-2026
On March 25, 2026, the Board of Directors of High Roller Technologies, Inc. (ROLR), upon recommendation of the Compensation Committee, approved discretionary cash bonuses of $250,000 to CEO Seth Young and $50,000 to CFO Adam Felman. This action falls under Item 5.02 of the 8-K filing related to compensatory arrangements for certain officers. No officer departures, elections, or other changes were reported.
31-03-2026
Prologis, L.P. entered into a Second Amended and Restated Global Senior Credit Agreement on March 26, 2026, with Bank of America, N.A. as Global Administrative Agent and a syndicate of lenders including ING Bank N.V., JPMorgan Chase Bank, N.A., and others, establishing U.S. and Euro committed loans, letters of credit, swing line facilities, and bid loans. The agreement includes provisions for global impact and sustainability, with CUSIPs assigned for the deal (74340YBP3), U.S. tranche (74340YBQ1), and Euro tranche (74340YBR9). No specific commitment amounts or financial metrics are detailed in the provided filing excerpt.
- ·Filing date: March 31, 2026
- ·Items reported: 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation), 9.01 (Financial Statements and Exhibits)
- ·Deal CUSIP: 74340YBP3; U.S. Tranche CUSIP: 74340YBQ1; Euro Tranche CUSIP: 74340YBR9
31-03-2026
Ares Holdings L.P., a key subsidiary of Ares Management Corp, entered into a new Credit Agreement dated March 27, 2026, establishing a U.S. Dollar three-year delayed draw term loan facility with Bank of America, N.A. as administrative agent and BOFA Securities, Inc. as sole lead arranger and bookrunner. The agreement includes standard representations, covenants, and definitions such as Adjusted EBITDA with restrictions on fee inclusions (no more than 15% from Designated Subsidiaries or 5% from Unrestricted Subsidiaries), but no specific commitment amounts or draw details are provided in the filing excerpt.
- ·Applicable Margin for Term SOFR Rate Loans ranges from 0.750% (Level I) to 1.250% (Level V) based on Ares Parent’s senior long-term unsecured debt ratings from S&P/Fitch/Moody’s.
- ·Agreement filed as Exhibit 10.1 in 8-K on March 31, 2026 under Items 1.01, 2.03, 9.01.
31-03-2026
Red Cat Holdings, Inc. entered into a Share Purchase Agreement on March 30, 2026, to acquire all issued and outstanding capital stock of Quaze Technologies, Inc. through its wholly-owned subsidiary 9563-4747 Quebec Inc. for approximately $25,000,000 in shares of Company common stock, subject to adjustments for indebtedness, transaction expenses, and net working capital. Additional earnout consideration of up to $5,000,000 in shares is payable upon achieving certain integration, revenue, and gross margin thresholds.
- ·Acquisition closing subject to customary conditions including regulatory approvals, accuracy of representations and warranties, and continued Nasdaq listing of RCAT common stock.
- ·Purchase Agreement terminable if closing conditions not met by December 31, 2026.
31-03-2026
On March 30, 2026, Satellogic Inc. entered into a Sales Agreement with Cantor Fitzgerald & Co., Craig-Hallum Capital Group LLC, Northland Securities, Inc., and Roth Capital Partners, LLC, enabling the company to offer and sell up to $50,000,000 of its Class A common stock through an at-the-market offering. The Sales Agents will use commercially reasonable efforts to sell shares based on the company's instructions, with the company providing customary indemnification and reimbursements. A prospectus supplement was filed on the same day under the company's Form S-3 registration statement (File No. 333-294446).
- ·Registration statement on Form S-3 (File No. 333-294446) initially filed March 19, 2026; base prospectus dated March 27, 2026.
- ·Securities registered: Class A Common Stock (SATL) and Warrants (SATLW) on Nasdaq Capital Market.
- ·Legal opinion on share issuance provided by King & Spalding LLP (Exhibit 5.1).
31-03-2026
EOS Energy Enterprises, Inc. entered into a new employment agreement with its Chief Administration Officer, Michelle Buczkowski, on March 30, 2026, superseding her prior offer letter. The agreement sets an annual base salary of $385,000, eligibility for a target year-end bonus of 75% of base salary, and annual long-term incentive grants. It also includes severance provisions for involuntary termination, such as 12 months of continued base salary and accelerated vesting of certain equity awards.
- ·Severance includes prorated annual bonus if three full months of service completed in applicable year.
- ·Non-competition and non-solicitation restrictions apply for 12 months post-termination.
- ·Customary confidentiality and intellectual property assignment obligations are perpetual.
31-03-2026
BMO Commercial Mortgage Securities LLC, as Depositor, executed a Pooling and Servicing Agreement dated as of March 1, 2026, for the BMO 2026-5C14 Mortgage Trust, establishing the framework for Commercial Mortgage Pass-Through Certificates, Series 2026-5C14, including conveyance of mortgage loans, servicing duties, and distributions to certificateholders. Key service providers include Midland Loan Services, a division of PNC Bank, N.A. (Master Servicer), CWCapital Asset Management LLC (Special Servicer), Pentalpha Surveillance LLC (Operating Advisor and Asset Representations Reviewer), and Computershare Trust Company, N.A. (Certificate Administrator and Trustee). The agreement details administrative, servicing, and compliance provisions with no specific financial performance metrics or period-over-period comparisons disclosed.
- ·No Class S Certificates, Class VRR Certificates, or Loan-Specific Certificates will be issued under this Agreement
- ·Agreement filed as Exhibit 99.1 in 8-K on March 31, 2026
31-03-2026
Ellington Credit Company entered into an indenture with Wilmington Trust, National Association for a public offering of $50 million aggregate principal amount of 8.50% Notes due 2031, with underwriters holding an option to purchase up to an additional $7.5 million within 30 days. The Notes, issued in $25 denominations, bear interest at 8.50% per year payable quarterly starting June 30, 2026, mature on March 30, 2031, and are expected to trade on the NYSE under 'ELLA'. They rank as general unsecured senior obligations, redeemable at 100% principal plus accrued interest on or after March 30, 2028.
- ·Notes issued in denominations of $25 and integral multiples thereof
- ·Redeemable in whole or in part on or after March 30, 2028, at 100% of principal plus accrued interest
- ·Indenture includes covenant to comply with 1940 Act asset coverage requirements
- ·Trading expected to commence within 30 days of original issue date
31-03-2026
Ponce Financial Group, Inc. appointed Marlene Cintron, a current member of Ponce Bank, NA's Board of Directors, to its own Board effective March 26, 2026. Cintron brings over three decades of experience in economic development, public policy, finance, and community advocacy, including leadership roles at Citibank, Merrill Lynch, BOEDC, and as SBA Region 2 Administrator where she oversaw a 20% increase in small business growth. The appointment is expected to strengthen leadership focused on community investment and growth.
- ·Marlene Cintron holds a law degree from Georgetown University and a master’s degree in education administration from Fordham University.
- ·Cintron served as a mayoral appointee to the NYCEDC board and gubernatorial appointee to the Regional Economic Development Council.
- ·Ponce Bank, N.A. is a Minority Depository Institution, Community Development Financial Institution, and certified SBA lender.
31-03-2026
On March 20, 2026, Steven Richards notified the Shimmick Corporation Board of his retirement, effective at the end of his term at the 2026 annual meeting of stockholders. Mr. Richards, who served as CEO from March 2020 through December 2024 and guided the company's November 2023 IPO, has been with the company for 45 years. In connection with his retirement, the Board expects to reduce its size to five members.
- ·Company is an emerging growth company
- ·Common Stock trades on NASDAQ under SHIM with $0.01 par value
31-03-2026
Goosehead Insurance, Inc. announced the appointment of Martin Thornthwaite as General Counsel and Corporate Secretary, effective March 30, 2026, bringing experience from RealPage, Inc., Clark Hill PLC, and Strasburger & Price LLP. Simultaneously, John O’Connor is departing the company to pursue other opportunities. The leadership change occurs as Goosehead continues to grow as an independent personal lines insurance agency representing over 200 insurance companies.
- ·Filing date: March 31, 2026
- ·Appointment effective date: March 30, 2026
- ·Investor contact: Phone (972) 800-1993, Email: madeline.middleton@goosehead.com or IR@goosehead.com
31-03-2026
First Foundation Inc. amended Simone Lagomarsino's employment agreement as President and Chief Risk Officer, extending the term to December 31, 2027, and entered a new employment agreement with James Britton as EVP and CFO, including a $390,000 annual base salary and severance provisions. The company also announced receipt of Federal Reserve approval for its merger with FirstSun Capital Bancorp, with all stockholder and regulatory approvals now obtained and closure expected on April 1, 2026. These actions ensure executive continuity ahead of the merger with no reported disruptions.
- ·Lagomarsino Amendment: No other material changes to original February 11, 2025 agreement.
- ·Britton severance: Lump sum equal to lesser of 12 months base salary or remaining term if terminated without cause or for good reason.
- ·Britton death benefit: 100% of base annual salary to beneficiaries.
- ·Britton: No severance if terminated for cause or upon term expiration (December 31, 2027).
31-03-2026
Cyabra, Inc. (f/k/a Trailblazer Holdings, Inc.) completed its previously announced business combination with Trailblazer Merger Corporation I, a blank-check SPAC, approved by stockholders on February 18, 2026, with closing on March 27, 2026. The combined company, operating as Cyabra, Inc. under CEO Dan Brahmy, expects its common stock to begin trading on Nasdaq under ticker 'CYAB' on March 27, 2026, while Trailblazer's prior tickers 'TMBC' and 'TMBCR' will cease trading. This positions Cyabra as the first publicly traded company dedicated to fighting disinformation by analyzing online manipulation.
- ·Stockholder approval at special meeting: February 18, 2026
- ·Legal advisors to Cyabra: Lowenstein Sandler LLP, Goldfarb Gross Seligman; Financial advisor: LifeSci Capital
- ·Legal advisors to Trailblazer: Loeb & Loeb LLP, Sullivan & Worcester LLP
- ·Cyabra website: www.cyabra.com; Trailblazer website: www.trailblazermergercorp.com
31-03-2026
Allbirds, Inc. (BIRD) entered a definitive asset purchase agreement with American Exchange Group (AXNY) to sell all intellectual property and certain assets/liabilities for an estimated $39 million, subject to shareholder approval via proxy statement by April 24, 2026, with closing expected in Q2 2026 followed by dissolution and net proceeds distribution in Q3 2026. The company cancelled its Q4 and FY 2025 earnings call scheduled for March 31, 2026, and plans to file its 10-K for the year ended December 31, 2025 on that date. While CEO Joe Vernachio highlighted the brand's legacy and future potential under AXNY, the transaction signals the end of Allbirds as an operating entity.
- ·Proxy statement expected no later than April 24, 2026
- ·Transaction close anticipated in Q2 2026
- ·Stockholder distribution of net proceeds (after wind-down expenses) anticipated in Q3 2026
- ·TD Cowen acting as financial advisor; Holland & Hart LLP as legal counsel to Allbirds
- ·Annual Report on Form 10-K for year ended December 31, 2025 to be filed March 31, 2026
31-03-2026
Lipella Pharmaceuticals Inc. and certain subsidiaries filed voluntary petitions for Chapter 11 bankruptcy relief in the United States Bankruptcy Court for the Western District of Pennsylvania on March 30, 2026. The filing warns that trading in the company's common stock during the Chapter 11 proceedings is highly speculative and carries substantial risks, with stock prices potentially unrelated to any shareholder recovery.
- ·Registrant is an emerging growth company.
- ·No securities registered pursuant to Section 12(b) of the Act.
- ·Exhibit 99.1: Press Release dated March 30, 2026.
31-03-2026
Skillsoft (NYSE: SKIL) appointed Art Gilliland, CEO of Delinea, to its Board of Directors effective March 25, 2026, bringing over 25 years of experience in cybersecurity, enterprise software, and AI leadership from roles at Symantec, Broadcom, Skyport Systems, HP, and others. CEO Ron Hovsepian highlighted Gilliland's expertise in scaling businesses and AI as key to Skillsoft's growth in AI-native skills management. The company supports a global community of more than 105 million learners and is trusted by 60% of the Fortune 1000.
- ·Art Gilliland holds a bachelor’s degree in Economics from Carleton College and a Master’s of Business Administration from Harvard Business School.
- ·Gilliland serves on the boards of OneSpan (OSPN) and Gigamon, and is a member of Forbes Technology Council and The Wall Street Journal Leadership Institute.
- ·Investor contact: Ross Collins at SKIL@alpha-ir.com; Media contact: Vito Gallo at vito.gallo@skillsoft.com.
31-03-2026
Immunic, Inc. (Nasdaq: IMUX) appointed Jon Congleton, a biopharmaceutical executive with nearly 40 years of experience including key roles in the U.S. launch of Copaxone® for multiple sclerosis and current CEO of Mineralys Therapeutics, Inc., to its Board of Directors effective March 27, 2026. This move aims to strengthen leadership expertise in CNS and commercialization as the company advances vidofludimus calcium (IMU-838) through phase 3 trials for relapsing multiple sclerosis, with top-line data expected by end of 2026. No financial impacts or performance metrics were disclosed.
- ·Appointment effective March 27, 2026
- ·Top-line data for IMU-838 phase 3 trials in relapsing MS expected by end of 2026
- ·Jon Congleton's experience: nearly 40 years in biopharmaceuticals, including U.S. neuroscience business at Teva
31-03-2026
SCYNEXIS, Inc. (NASDAQ: SCYX) announced the completion of its acquisition of SCY-770 (formerly PXL-770), a clinical-stage oral AMPK activator from Poxel S.A., for an upfront payment of $8M plus up to $8M in development milestones and $180M in commercial milestones to treat ADPKD. The company plans to initiate a Phase 2 proof-of-concept study in Q4 2026 with an early efficacy readout in 2H 2027, strengthening its rare disease pipeline alongside antifungal assets like BREXAFEMME (licensed to GSK) and SCY-247. SCY-770 has Orphan Drug Designation and a favorable safety profile from eight prior clinical trials, targeting a U.S. market of 140,000 ADPKD patients.
- ·SCY-770 evaluated in eight clinical trials with favorable safety profile and Orphan Drug Designation by FDA.
- ·Conference call scheduled for March 31, 2026 at 8:30 a.m. ET (U.S. Dial-in: 1-877-704-4453; International: 201-389-0920; Conference ID: 13759746).
- ·SCY-247 Phase 1 IV data expected Q3 2026; has QIDP, Fast Track, and Orphan Drug designations.
- ·BREXAFEMME outlicensed to GSK with low-to-mid single-digit royalties.
31-03-2026
SCYNEXIS, Inc. announced a $40.0 million private placement of common shares, pre-funded warrants, and common warrants, with potential additional gross proceeds of up to $52.2 million upon full exercise of common warrants subject to stockholder approval. The net proceeds, combined with existing cash, are expected to fund operations into mid-2029. The transaction includes participation from institutional investors and CEO Dr. David Angulo, who purchased 108,695 shares.
- ·Closing expected on or about April 1, 2026, subject to customary conditions
- ·Common Warrants exercisable at $1.20 per share after Stockholder Approval
- ·Common Warrants expire on the earlier of fifth anniversary of closing or 30 days after Week 48 topline data release from SCY-770 Phase 2 study
- ·Stockholder meeting to approve authorized share increase no later than 90 days after closing
- ·Common Shares and warrants sold at $0.92 combined price; Pre-Funded at $0.9199
31-03-2026
AlTi Global, Inc. (NASDAQ: ALTI) announced the appointment of Nancy Curtin as Interim Chief Executive Officer and to its Board of Directors, effective immediately, succeeding Michael Tiedemann who will remain available in an advisory capacity. The company, a leading global wealth manager, currently manages or advises on over $93 billion in assets with more than 450 professionals globally. Ms. Curtin, previously Global Chief Investment Officer, has led a team of more than 50 investment professionals and brings extensive experience from prior roles at Alvarium Investments and other firms.
- ·Filing date: March 31, 2026
- ·Ms. Curtin serves as Chairperson of the Board of Directors of Digital Bridge Group Inc.
31-03-2026
On March 26, 2026, Willis Warehouse Facility LLC, a wholly-owned subsidiary of Willis Lease Finance Corporation (WLFC), entered into a Credit Agreement Termination Agreement to terminate a prior credit agreement dated May 3, 2024, involving Bank of America as facility agent and Bank of Utah as administrative agent and security trustee. No financial terms, impacts, or reasons for termination are disclosed in this filing. The full text of the termination agreement will be included as an exhibit in WLFC's upcoming 10-Q for the period ended March 31, 2026.
- ·Filing made pursuant to Items 1.02 (Termination of a Material Definitive Agreement) and 9.01 (Exhibits).
- ·Date of earliest event reported: March 26, 2026.
- ·Securities: Common Stock, $0.01 par value per share (WLFC) on Nasdaq Global Market.
31-03-2026
BrightSpring Health Services, Inc. (NASDAQ: BTSG) completed the sale of its ResCare Community Living business to Sevita on March 31, 2026, following the definitive agreement announced in January 2025. The divestiture enables BrightSpring to focus on its Provider Services division, comprising Home Health Care, Personal Care, and Rehab Therapy services, while Sevita integrates the business to expand its community services. No financial terms of the transaction were disclosed in the filing.
- ·Definitive agreement for the sale was first announced in January 2025.
- ·BrightSpring provides services in all 50 states.
- ·Sevita operates in 40 states.
31-03-2026
SmartBank promoted Cynthia A. Cain to Chief Operating Officer, effective March 31, 2026, to oversee Operations, Technology, Data, AI Governance, Digital & Innovation, and Payments functions, strengthening leadership amid rapid industry changes. Ms. Cain brings more than 30 years of experience, including prior roles as Chief Accounting Officer at SmartBank since 2019 and Senior Vice President at South State Bank. The appointment positions the bank for long-term growth and operational excellence.
- ·SmartBank founded in 2007.
- ·Loan production offices in Columbus, Georgia, and Brentwood, Tennessee.
- ·Media contact: kelley.fowler@smartbank.com
31-03-2026
Barinthus Biotherapeutics plc announced that Gemma Jones, its principal accounting officer who provides services as an employee of CFGI, notified the company on March 27, 2026, that she will step down effective April 30, 2026. No successor has been named in the filing. The announcement is part of Item 5.02 of Form 8-K filed on March 31, 2026.
31-03-2026
On March 27, 2026, the Board of Directors of Yunhong Green CTI Ltd. (YHGJ) appointed Fred H.F. Chak as a Director, as disclosed in this Form 8-K filing under Items 5.02 and 8.01. The filing was signed by Jana M. Schwan, Chief Executive Officer, on March 31, 2026. No financial impacts, departures, or other material events were reported.
- ·Securities registered: Common Stock (YHGJ) on The Nasdaq Capital Market
- ·Registrant details: Incorporated in Illinois, Commission File Number 000-23115, IRS Employer Identification No. 36-2848943, Address: 22160 N. Pepper Road, Lake Barrington, IL 60010
31-03-2026
Toll Brothers, Inc. increased its Board size from 9 to 10 members and appointed Karl K. Mistry as a Director effective March 30, 2026, with his term expiring at the 2027 annual meeting. As part of its previously announced CEO succession plan, Mistry succeeded Douglas C. Yearley, Jr. as Chief Executive Officer, while Yearley assumed the role of Executive Chairman. No other changes, such as committee assignments or material transactions, were disclosed.
- ·Mr. Mistry is not expected to be appointed to any Board committee.
- ·No arrangements or understandings between Mr. Mistry and any other person for his selection as director.
- ·Mr. Mistry has no direct or indirect material interest in any transaction required to be disclosed under Item 404(a) of Regulation S-K.
31-03-2026
nCino reported record Q4 FY2026 total revenues of $149.7 million, up 6% YoY from $141.4 million, and FY2026 total revenues of $594.8 million, up 10% YoY from $540.7 million, with subscription revenues growing 7% to $133.4 million in Q4 and 12% to $523.1 million for the year. The company turned GAAP profitable with Q4 net income of $8.3 million (from -$18.6 million loss) and FY net income of $5.2 million (from -$37.9 million loss), while ACV reached $602.4 million, up 17% YoY (13% organic). Cash and equivalents declined to $88.7 million from $120.9 million prior year, with revolving credit facility outstanding at $213.5 million, amid announcement of a $100 million accelerated share repurchase funded by a $200 million term loan expansion.
- ·Q1 FY2027 guidance: Total revenues $154.5M-$156.5M; Subscription revenues $137.0M-$139.0M; Non-GAAP operating income $38.0M-$40.0M.
- ·FY2027 guidance: Total revenues $639.0M-$643.0M; Subscription revenues $569.0M-$573.0M; Non-GAAP operating income $165.0M-$170.0M; Free Cash Flow $132.0M-$137.0M; ACV $662.5M-$667.5M.
- ·New customer wins: Global bank with $2.0T assets in Japan for Commercial Lending; Expansion with $200B AUM bank; Top-40 U.S. bank for Mortgage; Top-3 Austrian bank for SME and Corporate Lending.
31-03-2026
On March 25, 2026, Chegg, Inc. rebalanced its Board of Directors by moving Renee Budig from Class I to Class III through a resignation and immediate re-election to achieve more equal class composition. The Board now consists of two Class I directors, one Class II director, and two Class III directors, with her service deemed uninterrupted. Ms. Budig will stand for election as a Class III director at the 2026 Annual Meeting on June 12, 2026, for a term ending at the 2028 Annual Meeting.
- ·Filing signed by David Longo on March 31, 2026.
- ·Rebalance effected solely for board class composition; no other changes to Ms. Budig's service.
31-03-2026
Advantage Solutions Inc. disclosed that Dean General, who transitioned to Chief Industry Development Officer on August 8, 2025, ceased serving as an executive officer effective March 26, 2026, per definitions under Rules 3b-7 and 16a-1(f) of the Securities Exchange Act. The filing, dated March 31, 2026, contains no financial impacts, compensatory details, or performance metrics related to this change.
- ·Previous disclosure of Dean General's role transition in Form 8-K filed August 8, 2025.
- ·No exhibits beyond Inline XBRL cover page (Exhibit 104).
31-03-2026
iPower Inc. amended a $2.3 million promissory note from ETTS AI Investment LLC, stemming from the February 1, 2026 sale of its subsidiary Global Product Marketing, Inc. (GPM). The March 26, 2026 amendment expands the 'Change of Control' definition to include material changes in executive management/board composition, business model/core operations, or supply chain disposition, triggering automatic voiding of the note. While maintaining all other terms, this provides broader protections to ETTS AI, potentially increasing repayment risk for iPower with no offsetting benefits disclosed.
- ·Original agreements dated February 1, 2026: software asset transfer to GPM and stock purchase by ETTS AI.
- ·Amendment filed as Exhibit 10.1; only Section 8 amended, all other note terms unchanged.
31-03-2026
On March 30, 2026, David Furstenberg resigned as a member of the Board of Directors and Audit Committee of Selectis Health, Inc., effective immediately. The company thanked him for his service and support. No successor or additional details on the resignation were provided.
- ·Filing dated March 31, 2026, reporting event of March 30, 2026
- ·Registrant is an emerging growth company
31-03-2026
Effective March 25, 2026, Jeff Woolard, Chief Financial Officer of Cirrus Logic, Inc., assumed the additional role of Principal Accounting Officer. Ulf Habermann ceased serving as Principal Accounting Officer but will continue in a senior role within the Company's finance organization. The transition was not due to any disagreement, and Woolard's compensation remains unchanged.
- ·Information regarding Mr. Woolard’s background, business experience, compensation arrangements, and related party transactions is incorporated by reference from the Company’s proxy statement on Schedule 14A filed June 4, 2025.
- ·The Form 8-K was signed by Jeff Woolard on March 31, 2026.
31-03-2026
Crown Holdings, Inc. (NYSE: CCK) appointed Dr. John M. Rost as Executive Vice President and Chief Operating Officer – Asia Pacific and Transit Packaging, effective April 1, 2026. Previously President of the Asia Pacific region based in Singapore, Dr. Rost will now oversee Asia Pacific and global Transit Packaging operations from Tampa, FL, reporting to Timothy J. Donahue, Chairman, President and CEO. The promotion recognizes his enhancements to partner relationships, volume growth in Asia-Pacific, and leadership in technology, sustainability, and the Twentyby30 program.
- ·Announcement date: March 26, 2026
- ·Dr. Rost joined Crown in 1997; previously Senior Vice President – Technology, Sustainability and Regulatory Affairs
- ·Dr. Rost holds a Bachelor of Science in Chemistry from Northern State University and a Ph.D. in Organic Chemistry from Loyola University Chicago
- ·Investor contact: Thomas T. Fischer, (215) 552-3720
31-03-2026
Mag Magna Corp., a rare earth elements mining company, entered into Lock-Up and Leak-Out Agreements effective March 27, 2026, with 11 consultants covering 8,900,000 shares (89% of 10,000,000 shares issued under its 2026 Stock Incentive Plan and S-8 Registration Statement). The agreements prohibit sales through December 31, 2026 (lock-up period), followed by a leak-out period through June 30, 2027, with monthly limits of 100,000 shares and daily limits of 20,000 shares, intended to promote stock price stability. Early termination is possible if the stock trades above $5.00 for 10 consecutive days post-lock-up.
- ·Lock-up Period ends December 31, 2026; Leak-out Period from January 1 to June 30, 2027
- ·Agreements include mutual release of claims and apply to transferees
- ·Board may discretionarily reduce, remove, or waive resale restrictions
- ·Company acquired first mining properties in January 2026
31-03-2026
On March 25, 2026, Texas Critical Data Centers LLC (TCDC), a wholly owned subsidiary of New Era Energy & Digital, Inc., entered into amendments to special warranty deeds for 235 acres and 205 acres of property with Odessa Industrial Development Corporation d/b/a Grow Odessa, eliminating most repurchase rights in exchange for a total payment of $4,347,500 ($1,000,000 cash and $3,347,500 promissory note due July 20, 2026, at 3.7% interest), securing property for development but adding short-term debt. On March 31, 2026, the Company issued 2,091,351 shares of common stock to SharonAI, Inc. as partial consideration under a January 16, 2026 Membership Interest Purchase Agreement, resulting in equity dilution.
- ·Promissory note allows prepayment at any time prior to maturity.
- ·Deed amendments retain limited repurchase right by Grow Odessa only if TCDC fails to begin Phase I construction within 2 years of recording.
- ·Shares issued under Section 4(a)(2) exemption from Securities Act registration.
31-03-2026
Lincoln National Corporation entered into a Third Amended and Restated Credit Agreement on March 27, 2026, with a syndicate of banks led by Bank of America, N.A., providing unsecured borrowing and letter of credit capacity of up to $2.0 billion maturing on March 27, 2031. The agreement replaces the prior facility dated December 21, 2023, and includes fees of 1.0% per annum on syndicated letters of credit and 0.125% per annum facility fee, both adjustable with credit ratings changes, along with financial covenants such as a minimum consolidated net worth of $9,932,000,000 plus 50% of post-December 31, 2025 equity proceeds, a debt-to-capital ratio not exceeding 0.35:1.00, and a 7.5% cap on certain non-operating indebtedness.
- ·Agreement contains customary covenants restricting liens, mergers/consolidations where LNC is not surviving entity, and dispositions of all/substantially all assets.
- ·Events of default include payment/covenant defaults, cross-defaults, bankruptcy, with termination rights and acceleration upon occurrence.
- ·Previous credit agreement dated December 21, 2023.
31-03-2026
On March 27, 2026, C. Jack Read informed MSCI Inc. of his intention to resign as Global Controller and Chief Accounting Officer to pursue another opportunity, with his service continuing until August 9, 2026. His departure was not due to any disagreement with the company regarding financial statements, internal controls, operations, policies, or practices. MSCI has initiated a search for a successor.
- ·Filing date: March 31, 2026
- ·Event reported date: March 27, 2026
- ·Mr. Read will remain principal accounting officer until August 9, 2026
31-03-2026
State Street Corporation appointed C. Jack Read as Executive Vice President, Global Controller and Chief Accounting Officer, effective August 10, 2026, succeeding Elizabeth M. Schaefer. The appointment was made on March 27, 2026, via a letter agreement providing Mr. Read an annualized base salary of $450,000, target 2026 incentive compensation of $2,100,000, and one-time transition payments of $1,730,000 in deferred stock and $700,000 in cash. No financial performance metrics or period-over-period comparisons were disclosed.
- ·C. Jack Read, age 57, served as Managing Director, Global Controller and Chief Accounting Officer at MSCI Inc. since August 2024, and previously as Executive Vice President, Controller and Chief Accounting Officer at Citizens Financial Group from August 2018 to August 2024.
- ·Prior to Citizens, Mr. Read held senior roles at MUFG Americas, JPMorgan Chase, Washington Mutual Bank, and was a tax advisory partner at KPMG.
- ·Filing signed by Mark Shelton on March 31, 2026.
31-03-2026
Santander Holdings USA, Inc. (SHUSA), Santander Bank, National Association (SBNA), and Webster Bank, National Association (WBNA) entered into an Agreement and Plan of Merger dated March 30, 2026, providing for the contribution of WBNA shares to SBNA for no consideration followed immediately by the merger of WBNA into SBNA, with SBNA as the surviving Resulting Bank. This Bank Merger is an intermediate step contingent on prior transactions, including the acquisition of Webster Financial Corporation by Banco Santander, S.A. via HoldCo Transactions, Webster Virginia Contribution, and IHC Merger, all aimed at regulatory compliance and tax efficiency under Sections 332 or 368(a) of the Internal Revenue Code. The transaction requires OCC approval, with SBNA retaining its name, main office in Wilmington, DE, board composition including directors from both entities, and all assets/liabilities vesting in the Resulting Bank.
- ·Agreement approved unanimously by boards of SBNA, SHUSA, and WBNA.
- ·Resulting Bank main office: 824 N. Market Street, Suite 100, Wilmington, DE 19801.
- ·WBNA main office: 1959 Summer Street, Stamford, CT 06905.
- ·Effective Time not earlier than effective time of HoldCo Transactions.
- ·WBNA capital stock shares cancelled with no consideration.
- ·Resulting Bank board to include John R. Ciulla, Luis Massiani, and two WBS directors.
- ·Transaction Agreement for HoldCo Transactions dated February 3, 2026.
Get daily alerts with 12 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 50 filings
🇺🇸 More from United States
View all →March 26, 2026
US Pre-Market SEC Filings Roundup — March 26, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
Biotech Small-Cap Approvals — March 25, 2026
Biotech Small-Cap Approvals
March 25, 2026
New Drug Approvals (Original) — March 25, 2026
New Drug Approvals (Original)